Skip to main content

Table 4 Cox regression analyses of overall survival in CSCC patients

From: HPV16 E6-specific T cell response and HLA-A alleles are related to the prognosis of patients with cervical cancer

Factors

OS (univariate analysis)

OS (multivariate analysis)

HR (95% CI)

P-value

HR (95% CI)

P-value

Age

1.755 (0.845–3.645)

0.131

Stage

1.281 (0.625–2.625)

0.499

Tumor size

1.307 (0.637–2.680)

0.466

Tumor type

1.279 (0.872–1.877)

0.208

Histologic grade

0.863 (0.572–1.302)

0.482

HPV

1.509 (0.671–3.394)

0.320

Pelvic lymph nodes

2.186 (1.037–4.605)

0.040

2.053 (0.958–4.397)

0.064

Therapy

0.475 (0.232–0.975)

0.042

0.425 (0.205–0.881)

0.021

Multiple overlapping-peptide response

0.227 (0.031–1.666)

0.145

0.307 (0.040–2.352)

0.256

HLA A*02:07

3.042 (1.348–6.862)

0.007

2.914 (1.270–6.686)

0.012

  1. HPV, human papillomavirus; HLA, human leukocyte antigen